Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study CANCER MED-US
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes J Clin Oncol
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research TRANSPL CELL THER
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS BLOOD CANCER J
Unexpected thermodynamic signature for the interaction of hydroxymethylated DNA with MeCP2 INT J BIOL MACROMOL
VHrare study: Prevalence, clinical features and management of severe rare bleeding disorders in a large cohort BRIT J HAEMATOL
Feasibility of a New Model of Care for Allogeneic Stem Cell Transplantation Recipients Facilitated by eHealth: The MY-Medula Pilot Study TRANSPL CELL THER
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial J Clin Oncol
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo PHARMACEUTICS
Effect of CD34+Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide TRANSPL CELL THER